4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001062993-25-012406
Options or other derivatives
- Chief Operating Officer acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Sandler Laura Lee Chief Operating Officer | 2025-07-01 | Grant or award · Employee Stock Option (right to buy) | +25,000 | 25,000 | D | ||
Loading xslF345X05/form4.xml…